Latest news


Step Pharma Presents Encouraging Data on its First-in-Class CTPS1 Inhibitor STP938 at the European Hematology Association Congress

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today announced the appointment of Andrew Parker, Ph.D., as Chief…

Read More

Step Pharma to Present Promising Data on the Therapeutic Potential of Selective Small Molecule Inhibition of CTPS1 at the European Hematology Association Congress 2022

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today announced the appointment of Andrew Parker, Ph.D., as Chief…

Read More

Step Pharma Strengthens Clinical Development Team Ahead of First in Human Studies

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today announced the appointment of Andrew Parker, Ph.D., as Chief…

Read More

Step Pharma Establishes Clinical Advisory Board

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today announced the appointment of Andrew Parker, Ph.D., as Chief…

Read More

Step Pharma Appoints Experienced Cancer Drug Developer Adrian Senderowicz to Board of Directors

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today announced the appointment of Andrew Parker, Ph.D., as Chief…

Read More

Meet the Team: Duc Tran, Chief Development Officer

Paris, France, 6 September 2019 – Step Pharma, a biotech company developing novel drugs for autoimmune diseases, today announced the appointment of Andrew Parker, Ph.D., as Chief…

Read More

Upcoming events

Step Pharma will be present at the following events

Nothing found.

Share this page